JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Argyle, S. A.
Right arrow Articles by McGrath, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Argyle, S. A.
Right arrow Articles by McGrath, J. C.

Vol. 295, Issue 2, 627-633, November 2000

An alpha 1A/alpha 1L-Adrenoceptor Mediates Contraction of Canine Subcutaneous Resistance Arteries1

Sally Anne Argyle and John Christie McGrath

Autonomic Physiology Unit, Division of Neuroscience and Biomedical Systems, Institute of Biomedical & Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom

To determine the characteristics of the alpha 1-adrenoceptor subtypes involved in adrenergic regulation of peripheral vascular resistance, contraction of canine subcutaneous resistance arteries was studied using wire myographs. The potencies of agonists and antagonists, chosen for their ability to discriminate between alpha 1-adrenoceptor subtypes, were assessed in the presence of cocaine (3 µM), corticosterone (30 µM), and propranolol (1 µM). The rank order of agonist potency (pEC50 ± S.E.) was (R)-A-61603 (7.88 ± 0.1) > norepinephrine (6.41 ± 0.1) > phenylephrine (5.83 ± 0.1). The high sensitivity to (R)-A-61603 relative to phenylephrine is inconsistent with the presence of the alpha 1D-adrenoceptor and most consistent with an alpha 1A-adrenoceptor response. This is supported by the low affinity for the alpha 1D-selective antagonist BMY 7378 (pKB 6.51 ± 0.47). The low pA2 values for prazosin (8.36) and HV723 (8.81), by definition, indicate the involvement of the putative alpha 1L-adrenoceptor, a hypothesis supported by the pA2 values for WB4101 (8.42) and 5-methyl-urapidil (8.08). Pre-exposure to 1 µM CEC had little effect, whereas 100 µM CEC reduced the maximum contraction but not the sensitivity to norepinephrine. This low sensitivity to CEC argues against the presence of the alpha 1B-adrenoceptor. We conclude that, by current definitions, an alpha 1A-/alpha 1L-adrenoceptor causes contraction of these vessels. This does not support the concept that selectivity for the alpha 1A-adrenoceptor is the basis for the effectiveness of some alpha -blockers in some tissues, such as prostate, but not in other tissues such as blood vessels. Rather, the generally low potency of alpha -blockers in some tissues may be due to a tissue-specific property of the receptors.


1 This work was funded by a Glasgow University Scholarship and the Clinical Research Initiative in heart failure. The work was presented in part at the IUPHAR Congress 1998 (Argyle et al., 1998).


0022-3565/00/2952-0627$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Marti, R. Miquel, K. Ziani, R. Gisbert, M. D. Ivorra, E. Anselmi, L. Moreno, V. Villagrasa, D. Barettino, and P. D'Ocon
Correlation between mRNA levels and functional role of {alpha}1-adrenoceptor subtypes in arteries: evidence of {alpha}1L as a functional isoform of the {alpha}1A-adrenoceptor
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1923 - H1932.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. J. Daly, C. Deighan, A. McGee, D. Mennie, Z. Ali, M. McBride, and J. C. McGrath
A knockout approach indicates a minor vasoconstrictor role for vascular {alpha}1B-adrenoceptors in mouse
Physiol Genomics, May 10, 2002; 9(2): 85 - 91.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. Guimaraes and D. Moura
Vascular Adrenoceptors: An Update
Pharmacol. Rev., June 1, 2001; 53(2): 319 - 356.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.